Sorafenib Terminated Phase 3 Trials for Hepatocellular Carcinoma / Liver Cell Carcinoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02460991A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma